Our Carla Verissimo, Head of Oncology II speaks about the current challenges of oncology drug development in this exclusive interview of the PREDiCT series.
Exclusive Interview with Carla Verissimo, Head of Oncology II, HUB Organoid Technology.
Our Carla Verissimo, Head of Oncology II speaks about the current challenges of oncology drug development in this exclusive interview of the PREDiCT series.
Exclusive Interview with Carla Verissimo, Head of Oncology II, HUB Organoid Technology.
and never miss an update!
Explore how patient-derived HUB Organoids can fast-track your clinical candidate selection
Decipher the complexity of human disease with our custom development services
